Malignant mesothelioma (MESO) consists of epithelioid, biphasic, and sarcomatoid
subtypes with different epithelial–mesenchymal transition (EMT) phenotypes. We previously …

Malignant mesothelioma (MESO) is a highly aggressive cancer with poor prognosis.
Epithelial–mesenchymal transition (EMT) is a critical process in malignancies involved in …

Objective. Mesothelioma (MESO) is a rare tumor derived from mesothelium cells. The aim of
this study was to explore key candidate genes and potential molecular mechanisms for …

Background Malignant mesothelioma is a type of infrequent tumor that is substantially
related to asbestos exposure and has a terrible prognosis. We tried to produce a fibroblast …

Purpose: Despite research efforts to develop more effective diagnostic and therapeutic
approaches, malignant pleural mesothelioma (MPM) prognosis remains poor. The …

Malignant mesothelioma is an aggressive cancer with limited treatment options and poor
prognosis. A better understanding of mesothelioma genomics and transcriptomics could …

PURPOSE Mesothelioma is an aggressive malignancy with heterogeneous outcomes that
are partly driven by the differential efficacy of existing therapies across histologic types and …

Malignant pleural mesothelioma (MPM) is a rare but highly aggressive thoracic malignancy.
ESTIMATE algorithm-derived immune scores are commonly used to quantify the immune …

Background Malignant mesothelioma (MM) is a highly aggressive cancer with a poor
prognosis. Despite the use of several well-known markers, the diagnosis of MM is still …

Malignant pleural mesothelioma (MPM) is a fatal disease of respiratory system. Despite the
availability of invasive biomarkers with promising results, there are still significant diagnostic …